NASDAQ
HLS Therapeutics Inc. (HLTRF) has a free cash flow growth of -2.04% as of Friday, May 29, 2026. This represents a 104.97% decrease compared to its 12-month average of 41.10%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.